PERSONAL HEALTH

SMART REPORT
A comprehensive analysis of your health using
Blood, Physicals, and Health Questionnaire data

Prepared for

R Aravind
Basic Info Patient ID
Male /42 Yrs OKH1425357

Report released on Date of Test

08/07/2024 07/07/2024
 Patient ID Date of Collection
OKH1425357 07/07/24

Table of contents
Your smart report includes the following sections.

S. No. Section Page No

01 Summary for Doctors 03

02 Your Wellbeing Index 06

03 Glance of Important Parameters 07

04 Wellness Recommendations 11

05 References 12

06 Lab Report

Disclaimer
• This is an electronically generated report and is not a • Analysis uses the attached blood test report and Well
substitute for medical advice. Being Index Questionnaire data, if present, and urine

• While following the recommendations, please be careful analysis report, if present.

of any allergies or intolerances. • Tata 1mg is not liable for any direct, indirect, special,

• If you are pregnant or lactating, some of the consequential, or other damages. This report cannot be

recommendations and analyzed information in the used for any medico-legal purposes. Partial reproduction

Smart Report may not directly apply to you. Please of the test results is not permitted. Also, TATA 1mg Labs is

consult a doctor regarding your test results and not responsible for any misinterpretation or misuse of the

recommendations. information.
 Patient ID Date of Collection
OKH1425357 07/07/24

For
Doctor Summary For R Aravind
Good Health Gold Package with Smart Report Male /42 Yrs

Note This is an electronically generated summary of the attached report. It is advised to read this summary in conjunction with the
attached report and to correlate it clinically. For the trends section, the out of range values are highlighted with respect to the
bio reference range of respective reports.

Test Name Result, 07/07/24 Bio. Ref. Interval Trends (For last three tests)

Complete Blood Count Date 1 Date 2 Date 3

Hemoglobin 15.3 g/dL 13.0 - 17.0

RBC 5.3 10^6/cu.mm 4.5 - 5.5
HCT 45 % 40 - 50
RDW-CV 14.3 % 11.6 - 14
Total Leucocyte Count 6.61 10^3/µL 4 - 10
Neutrophils 53.5 % 40 - 80
Lymphocytes 37.4 % 20 - 40
Monocytes 5.4 % 2 - 10
Eosinophils 2.9 % 1-6
Basophils 0.8 % 0-2
Platelet Count 293 10^3/µL 150 - 410

Diabetes Profile

Glycosylated Hemoglobin
6.2 % 4 - 5.6
(HbA1c)

Glucose - Fasting 105 mg/dL 70 - 99

We don't have any of your

Kidney Function Test
previous lab results for
Blood Urea Nitrogen 6.12 mg/dL 09 - 23
these tests in our records
Urea 13.1 mg/dl 19.26 - 49.22
Creatinine 0.82 mg/dL 0.70 - 1.30
Uric Acid 6.9 mg/dL 3.5 - 7.2
Sodium 141 mmol/L 132 - 146
Potassium 4 mmol/L 3.5 - 5.5

Lipid Profile

Cholesterol - Total 177 mg/dL 0 - 200

Triglycerides 204 mg/dL <= 149
Cholesterol - HDL 22.7 mg/dL >= 40

Page 3/12
 Patient ID Date of Collection
OKH1425357 07/07/24

For
Doctor Summary For R Aravind
Good Health Gold Package with Smart Report Male /42 Yrs

Note This is an electronically generated summary of the attached report. It is advised to read this summary in conjunction with the
attached report and to correlate it clinically. For the trends section, the out of range values are highlighted with respect to the
bio reference range of respective reports.

Test Name Result, 07/07/24 Bio. Ref. Interval Trends (For last three tests)

Lipid Profile Date 1 Date 2 Date 3

Cholesterol - LDL 113.5 mg/dL 30 - 99.9

Cholesterol- VLDL 40.8 mg/dl <= 29.9
Cholesterol : HDL
7.8 Ratio 3.5 - 4.5
Cholesterol

LDL : HDL Cholesterol 5 Ratio 2.5 - 3

Non HDL Cholesterol 154.3 mg/dl 0 - 129.9

Liver Function Test

Bilirubin - Total 0.81 mg/dl 0.3 - 1.2

Protein, Total 7.87 g/dL 5.7 - 8.2
Albumin 4.39 g/dL 3.4 - 4.8
Aspartate Transaminase
25 U/L 0 - 34
(SGOT)

Alanine Transaminase
37 U/L 10 - 49
(SGPT)

Alkaline Phosphatase 67 U/L 46 - 116

Gamma
24 U/L <= 72 We don't have any of your
Glutamyltransferase (GGT)
previous lab results for
Urine Routine & Microscopy these tests in our records
Specific gravity 1.025 1.003 - 1.035
pH 6 4.6 - 8
Glucose Negative NEGATIVE
Protein Negative NEGATIVE
Ketones Negative NEGATIVE
Pus cells 1-2 /hpf 0-5
Red blood cell Nil /hpf 0-2
Epithelial cells 1-2 /hpf FEW
Casts Nil /lpf NIL

Page 4/12
 Patient ID Date of Collection
OKH1425357 07/07/24

For
Doctor Summary For R Aravind
Good Health Gold Package with Smart Report Male /42 Yrs

Note This is an electronically generated summary of the attached report. It is advised to read this summary in conjunction with the
attached report and to correlate it clinically. For the trends section, the out of range values are highlighted with respect to the
bio reference range of respective reports.

Test Name Result, 07/07/24 Bio. Ref. Interval Trends (For last three tests)

Urine Routine & Microscopy Date 1 Date 2 Date 3

Crystals Nil NIL

Thyroid Function Test

T3, Total 1.23 ng/mL 0.60 - 1.81

T4, Total 9.5 µg/dl 4.5 - 12.6
Thyroid Stimulating
3.344 uIU/ml 0.55 - 4.78
Hormone - Ultra Sensitive

We don't have any of your

previous lab results for
these tests in our records

Page 5/12
 Patient ID Date of Collection
OKH1425357 07/07/24

For
Wellbeing Index R Aravind
Important Findings from your Wellbeing Index Male /42 Yrs

Physicals

Height Weight Waist BMI

Data not available Data not available Data not available Data not available

Heart Age BP
Data not available Data not available

Disease Risks

Diabetes Hypertension Stroke CVD

Survey not taken yet Survey not taken yet Survey not taken yet Survey not taken yet

Depression Anxiety Stress

Survey not taken yet Survey not taken yet Survey not taken yet

* Embark on a better you by completing the wellbeing index. Here

Lifestyle Data

Habits Family History

Data not available Data not available

Page 6/12
 Patient ID Date of Collection
OKH1425357 07/07/24

For
Important Parameters R Aravind
From your Good Health Gold Package with Smart Report Male /42 Yrs

Complete Blood Count

Gives an insight into the health of blood and blood cells which are essential to carry out various
bodily functions like transporting oxygen, fighting infections, and clotting blood after an injury.

Hemoglobin RBC HCT RDW-CV

15.3 g/dL 5.3 10^6/cu.mm 45 % 14.3 %

Range: 13.0 - 17.0 Range: 4.5 - 5.5 Range: 40 - 50 Range: 11.6 - 14

Total Leucocyte Count Neutrophils Lymphocytes Monocytes

6.61 10^3/µL 53.5 % 37.4 % 5.4 %

Range: 4 - 10 Range: 40 - 80 Range: 20 - 40 Range: 2 - 10

Eosinophils Basophils Platelet Count

2.9 % 0.8 % 293 10^3/µL

Range: 1 - 6 Range: 0 - 2 Range: 150 - 410

Diabetes Profile
Measures the level of glucose in the body and helps identify the body's ability to process glucose. It
can be used for screnning as well as monitoring the treatment of diabetes.

Glycosylated Hemoglobin (HbA1c) Glucose - Fasting

6.2 % 105 mg/dL

Range: 4 - 5.6 Range: 70 - 99

Page 7/12
 Patient ID Date of Collection
OKH1425357 07/07/24

For
Important Parameters R Aravind
From your Good Health Gold Package with Smart Report Male /42 Yrs

Kidney Function Test

Performed to determine how well the kidneys are working. Kidneys regulate elimination of waste from
our body and maintain electrolyte balance.

Blood Urea Nitrogen Urea Creatinine Uric Acid

6.12 mg/dL 13.1 mg/dl 0.82 mg/dL 6.9 mg/dL

Range: 09 - 23 Range: 19.26 - 49.22 Range: 0.70 - 1.30 Range: 3.5 - 7.2

Sodium Potassium
141 mmol/L 4 mmol/L

Range: 132 - 146 Range: 3.5 - 5.5

Lipid Profile
Measures the amount of Cholesterol and Triglycerides in your blood. This gives an insight into the
health of heart and blood vessels.

Cholesterol - Total Triglycerides Cholesterol - HDL Cholesterol - LDL

177 mg/dL 204 mg/dL 22.7 mg/dL 113.5 mg/dL

Range: 0 - 200 Range: <= 149 Range: >= 40 Range: 30 - 99.9

Cholesterol- VLDL Cholesterol : HDL Cholesterol LDL : HDL Cholesterol

40.8 mg/dl 7.8 Ratio 5 Ratio

Range: <= 29.9 Range: 3.5 - 4.5 Range: 2.5 - 3

Non HDL Cholesterol

154.3 mg/dl

Range: 0 - 129.9

Page 8/12
 Patient ID Date of Collection
OKH1425357 07/07/24

For
Important Parameters R Aravind
From your Good Health Gold Package with Smart Report Male /42 Yrs

Liver Function Test

Group of blood tests commonly performed to evaluate the function of the liver which is essential to
digest food and removing toxins from the body.

Bilirubin - Total Protein, Total Albumin

0.81 mg/dl 7.87 g/dL 4.39 g/dL

Range: 0.3 - 1.2 Range: 5.7 - 8.2 Range: 3.4 - 4.8

Aspartate Transaminase (SGOT) Alanine Transaminase (SGPT)

25 U/L 37 U/L

Range: 0 - 34 Range: 10 - 49

Alkaline Phosphatase Gamma Glutamyltransferase (GGT)

67 U/L 24 U/L

Range: 46 - 116 Range: <= 72

Urine Routine & Microscopy

Microscopic examination of urine sample to check for the presence of blood cells, crystals, bacteria,
parasites, and cells from tumors in it.

Specific gravity pH Glucose Protein

1.025 6 Negative Negative
Range: 1.003 - 1.035 Range: 4.6 - 8 Range: NEGATIVE Range: NEGATIVE

Ketones Pus cells Red blood cell Epithelial cells Casts

Negative 1-2 /hpf Nil /hpf 1-2 /hpf Nil /lpf

Range: NEGATIVE Range: 0 - 5 Range: 0 - 2 Range: FEW Range: NIL

Page 9/12
 Patient ID Date of Collection
OKH1425357 07/07/24

For
Important Parameters R Aravind
From your Good Health Gold Package with Smart Report Male /42 Yrs

Crystals
Nil
Range: NIL

Thyroid Function Test

Window to the health of the butterfly shaped gland - Thyroid, which detemines how the body uses
energy.

T3, Total T4, Total

1.23 ng/mL 9.5 µg/dl

Range: 0.60 - 1.81 Range: 4.5 - 12.6

Thyroid Stimulating Hormone - Ultra Sensitive

3.344 uIU/ml

Range: 0.55 - 4.78

Page 10/12
 Patient ID Date of Collection
OKH1425357 07/07/24

For
Recommendations R Aravind
Male /42 Yrs
Care for better health and wellbeing

Lifestyle

Healthy Do's Dont's

eating Consume A Listen To Your Body

Well-Balanced Diet Stop eating when you feel full and
Prioritize a balanced diet with fruits, avoid emptying your plate.
vegetables, whole grains, lean
proteins, nuts, healthy fats, and
omega-3s. Limit salt and unhealthy
fats.

Do's Dont's Sleep

Avoid A Large Meal Close Bedroom Clock hygiene
To Bedtime Avoid checking the time during the
Eat a healthy dinner early and avoid night, including on alarm clocks and
late-night snacks to promote better other devices. This can increase
sleep. mental activity and make it harder
to fall back asleep.

Exercise Do's

Park Farther Away Even 5 Minutes Of Exercise

Park farther and walk to promote Has Real Health Benefits.
physical activity, but prioritize Guidelines recommend 150-300
safety. minutes of moderate-intensity
activity per week for substantial
health benefits, with even 5 minutes
having real benefits.

Page 11/12
 Patient ID Date of Collection
OKH1425357 07/07/24

For
References R Aravind
Male /42 Yrs
From trusted sources

01 Estimation of 10-year Cardiovascular Disease (CVD) Risk

D'Agostino RB Sr, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study.Circulation. 2008
Feb 12;117(6):743-53

02 Framingham Heart Study: Hypertension Risk

Parikh NI, et al. A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study.Ann Intern Med.
2008;148(2):102-110.

03 Framningham Heart Study. Stroke Risk

D’Agostino RB, et al. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke.
1994;25(1):40-3.

04 Depression: Patient Health Questionnaire-2 (PHQ-2)

Kroenke K, et al. The Patient Health Questionnaire-2: validity of a two-item depression screener.Med Care. 2003;41(11):1284-1292.

05 Anxiety: Generalized Anxiety Disorder 2-item (GAD-2)

Kroenke K, et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.Ann Intern Med.
2007;146(5):317-325.

06 Anxiety: Generalized Anxiety Disorder 7-item (GAD-7)

Spitzer RL, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7.Arch Intern Med. 2006;166:1092-7.

07 Indian Diabetes Risk Score [IDRS]

Mohan V, et al. A simplified Indian Diabetes Risk Score for screening for undiagnosed diabetic subjects. J Assoc Physicians India.
2005;53:759-763.

08 Dietary Guidelines for Indians

Dietary Guidelines for Indians - A Manual, Second Edition, 2011.ICMR-National Institute of Nutrition, Hyderabad.

09 My plate for the day

R. Hemalatha. Promotionof ‘My Plate for the Day’ and physical activity among the population to prevent all forms of malnutrition
and NCDs in the country, 2023.ICMR-National Institute of Nutrition, Hyderabad.

10 Healthy Eating Plate

Building a Healthy and Balanced DietThe Nutrition Source, Department of Nutrition, Harvard T.H. Chan School of Public Health.

11 Top 10 Take-Home Messages for the Primary Prevention of Cardiovascular Disease

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019 Sep 10;140(11).

12 Smoking cessation
Age-friendly Primary Health Care Centres Toolkit. World Health Organization

13 Sleep Hygiene
Irish LA, et al. The role of sleep hygiene in promoting public health: A review of empirical evidence. Sleep Med Rev. 2015;22:23-36.

14 Body mass index (BMI)

Nutritional Status of Women and Men, 2019-21 India.National Family Health Survey (NFHS - 5), 2019–21.

***End of Smart Report***

Page 12/12
PO No :PO2064551203-659

Name : Mr.R ARAVIND Client Name : TATA 1MG OKHLA

Age/Gender : 42/Male Registration Date : 07/Jul/2024 11:18AM
Patient ID : OKH1425357 Collection Date : 07/Jul/2024 09:11AM
Barcode ID/Order ID : D11724214 / 9998317 Sample Receive Date : 07/Jul/2024 01:57PM
Referred By : Dr. Report Status : Final Report
Sample Type : WHOLE BLOOD-EDTA Report Date : 07/Jul/2024 06:13PM

HAEMATOLOGY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method

Glycosylated Hemoglobin (HbA1c) 6.2 % 4 - 5.6 HPLC (NGSP certified)

Estimated average glucose (eAG) 131.24 mg/dL Calculated

Comment:
Interpretation: HbA1c%

≤5.6 Normal
5.7-6.4 At Risk For Diabetes
≥6.5 Diabetes

Adapted from American Diabetes Association.

Comments:
A 3 to 6 monthly monitoring is recommended in diabetics. People with diabetes should get the test done more often if their blood
sugar stays too high or if their healthcare provider makes any change in the treatment plan. HbA1c concentration represent the
integrated values for blood glucose over the preceding 8-12 weeks and is not affected by daily glucose fluctuation, exercise &
recent food intake.
Please note, Glycemic goal should be individualized based on duration of diabetes, age/life expectancy, comorbid conditions,
known CVD or advanced microvascular complications, hypoglycemia unawareness, and individual patient considerations.

Factors that interfere with HbA1c Measurement: Hemoglobin variants, elevated fetal hemoglobin (HbF) and chemically modified
derivatives of hemoglobin (e.g. carbamylated Hb in patients with renal failure) can affect the accuracy of HbA1c measurements.

Factors that affect interpretation of HbA1c Measurement: Any condition that shortens erythrocyte survival or decrease mean
erythrocyte age (e. g., recovery from acute blood loss, hemolytic anemia, HbSS, HbCC, and HbSC) will falsely lower HbA1c test
results regardless of the assay method used. Iron deficiency anemia is associated with higher HbA1c.

Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered, particularly when the
HbA1c result does not correlate with the patient's blood glucose levels.

• HPLC - High performance liquid chromatography

This test has been performed at

TATA 1MG OKHLA
Address: 2nd Floor, B-225, Okhla Phase I,
Okhla Industrial Estate, New Delhi, Delhi
110020

Page 1 of 12
PO No :PO2064551203-659

Name : Mr.R ARAVIND Client Name : TATA 1MG OKHLA

Age/Gender : 42/Male Registration Date : 07/Jul/2024 11:18AM
Patient ID : OKH1425357 Collection Date : 07/Jul/2024 09:11AM
Barcode ID/Order ID : D11724214 / 9998317 Sample Receive Date : 07/Jul/2024 01:57PM
Referred By : Dr. Report Status : Final Report
Sample Type : Whole Blood-EDTA Report Date : 07/Jul/2024 04:30PM

HAEMATOLOGY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method

Complete Blood Count

Hemoglobin 15.3 g/dL 13.0-17.0 Cyanide Free SLS
RBC 5.30 10^6/cu.mm 4.5 - 5.5 Impedance
HCT 45.0 % 40 - 50 Calculated
MCV 84.9 fL 83 - 101 RBC pulse measurement
MCH 28.8 pg 27 - 32 Calculated
MCHC 33.9 g/dL 31.5 - 34.5 Calculated
RDW-CV 14.3 % 11.6-14 Calculated
Total Leucocyte Count 6.61 10^3/µL 4 - 10 Impedance
Differential Leucocyte Count
Neutrophils 53.5 % 40-80 Double hydrodynamic
sequential
system/Microscopy
Lymphocytes 37.4 % 20-40 Double hydrodynamic
sequential
system/Microscopy
Monocytes 5.4 % 2-10 Double hydrodynamic
sequential
system/Microscopy
Eosinophils 2.9 % 1-6 Double hydrodynamic
sequential
system/Microscopy
Basophils 0.8 % 0-2 Double hydrodynamic
sequential
system/Microscopy
Absolute Leucocyte Count
Absolute Neutrophil Count 3.54 10^3/µL 2-7 Calculated
Absolute Lymphocyte Count 2.47 10^3/µL 1-3 Calculated
Absolute Monocyte Count 0.36 10^3/µL 0.2-1 Calculated
Absolute Eosinophil Count 0.19 10^3/µL 0.02-0.5 Calculated
Absolute Basophil Count 0.05 10^3/µL 0.02-0.1 Calculated
Platelet Count 293 10^3/µL 150-410 Impedance /Microscopy

This test has been performed at

TATA 1MG OKHLA
Address: 2nd Floor, B-225, Okhla Phase I,
Okhla Industrial Estate, New Delhi, Delhi
110020

Page 2 of 12
PO No :PO2064551203-659

Name : Mr.R ARAVIND Client Name : TATA 1MG OKHLA

Age/Gender : 42/Male Registration Date : 07/Jul/2024 11:18AM
Patient ID : OKH1425357 Collection Date : 07/Jul/2024 09:11AM
Barcode ID/Order ID : D11724214 / 9998317 Sample Receive Date : 07/Jul/2024 01:57PM
Referred By : Dr. Report Status : Final Report
Sample Type : Whole Blood-EDTA Report Date : 07/Jul/2024 04:30PM

HAEMATOLOGY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method
MPV 9.1 fL 6.5 - 12 Calculated
PDW 14.9 fL 9-17 Calculated

Comment:
As per the recommendation of International council for Standardization in Hematology, the differential leucocyte counts are
additionally being reported as absolute numbers of each cell in per unit volume of blood.

This test has been performed at

TATA 1MG OKHLA
Address: 2nd Floor, B-225, Okhla Phase I,
Okhla Industrial Estate, New Delhi, Delhi
110020

Page 3 of 12
 PO No :PO2064551203-659

Name : Mr.R ARAVIND Client Name : TATA 1MG OKHLA

Age/Gender : 42/Male Registration Date : 07/Jul/2024 11:18AM
Patient ID : OKH1425357 Collection Date : 07/Jul/2024 09:11AM
Barcode ID/Order ID : D11724215 / 9998317 Sample Receive Date : 07/Jul/2024 01:23PM
Referred By : Dr. Report Status : Final Report
Sample Type : Fluoride Plasma F Report Date : 07/Jul/2024 03:45PM

BIOCHEMISTRY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method

Glucose - Fasting
Glucose - Fasting 105 mg/dL 70 - 99 Hexokinase

Fasting Plasma Glucose (mg/dL) 2 hr plasma Glucose (mg/dL) Diagnosis

99 or below 139 or below Normal
100 to 125 140 to 199 Pre-Diabetes (IGT)
126 or above 200 or above Diabetes

Reference : American Diabetes Association

Comment:
Impaired glucose tolerance (IGT) fasting, means a person has an increased risk of developing type 2 diabetes but does not
have it yet. A level of 126 mg/dL or above, confirmed by repeating the test on another day, means a person has diabetes.
IGT (2 hrs Post meal ), means a person has an increased risk of developing type 2 diabetes but does not have it yet. A 2-hour
glucose level of 200 mg/dL or above, confirmed by repeating the test on another day, means a person has diabetes

Plasma Glucose Goals For people with Diabetes

Before meal 70-130 mg/dL
2 Hours after meal Less than 180 mg/dL
Less than 7%
HbA1c

This test has been performed at

TATA 1MG OKHLA
Address: 2nd Floor, B-225, Okhla Phase I,
Okhla Industrial Estate, New Delhi, Delhi
110020

Page 4 of 12
PO No :PO2064551203-659

Name : Mr.R ARAVIND Client Name : TATA 1MG OKHLA

Age/Gender : 42/Male Registration Date : 07/Jul/2024 11:18AM
Patient ID : OKH1425357 Collection Date : 07/Jul/2024 09:11AM
Barcode ID/Order ID : D11724213 / 9998317 Sample Receive Date : 07/Jul/2024 01:21PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 07/Jul/2024 03:45PM

BIOCHEMISTRY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method

Lipid Profile
Cholesterol - Total 177 mg/dL Desirable <200, Enzymatic
Borderline High 200-239,
High >=240
Triglycerides 204 mg/dL Normal: <150, GPO
Borderline: 150 - 199,
High:200-499,
Very High>=500
Cholesterol - HDL 23 mg/dL Undesirable/high risk Elimination/catalase
<=40mg/dL
Desirable/low
risk>=60mg/dl
Cholesterol - LDL 114 mg/dL Desirable: <100 Calculated
Above desirable: 100 -
129
Borderline high : 130 -
159
High : 160 - 189
Very high : >=190
Cholesterol- VLDL 41 mg/dl <30 Calculated
Cholesterol : HDL Cholesterol 7.8 Ratio Desirable : 3.5-4.5 Calculated
High Risk : >5
LDL : HDL Cholesterol 5.00 Ratio Desirable : 2.5-3.0 Calculated
High risk : >3.5
Non HDL Cholesterol 154 mg/dl Desirable:< 130, Calculated
Above Desirable:130 -
159,
Borderline High:160 -
189,
High:190 - 219,
Very High: >= 220

Comment:

This test has been performed at

TATA 1MG OKHLA
Address: 2nd Floor, B-225, Okhla Phase I,
Okhla Industrial Estate, New Delhi, Delhi
110020

Page 5 of 12
PO No :PO2064551203-659

Name : Mr.R ARAVIND Client Name : TATA 1MG OKHLA

Age/Gender : 42/Male Registration Date : 07/Jul/2024 11:18AM
Patient ID : OKH1425357 Collection Date : 07/Jul/2024 09:11AM
Barcode ID/Order ID : D11724213 / 9998317 Sample Receive Date : 07/Jul/2024 01:21PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 07/Jul/2024 03:45PM

BIOCHEMISTRY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method
•Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial
samples 1 week apart may be tested.
•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe
with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.
•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.
•LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or
stroke and is the primary target for reducing risk for cardiovascular disease.
•High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.
•Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition
associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance.
Hence high triglyceride levels also need to be treated.
•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B).
Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin
therapy.
•Lipid Association of India (LAI-2020) recommends:-

Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile.
Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs
in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females
<50mg/dl).
Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for
managing Indian patients.
Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the co-
primary target for initiating drug therapy.
Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low
risk groups, treatment is started only after 3 months of lifestyle changes.
Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group.
Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC

New treatment goals by Lipid Association of India (2020)

CONSIDER THERAPY (cut-off level) TREATMENT GOALS
Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL)
<50 <80
Extreme Risk Gp Cat. A ≥50 ≥80
(Optional ≤30) (Optional ≤60)
Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60
Very High Risk ≥50 ≥80 <50 <80
High Risk ≥70 ≥100 <70 <100
Moderate Risk ≥100 ≥130 <100 <130
Low risk ≥130* ≥160* <100 <130
*After an adequate non-pharmacological intervention for at least 3 months

•As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9
- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening
is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension.

This test has been performed at

TATA 1MG OKHLA
Address: 2nd Floor, B-225, Okhla Phase I,
Okhla Industrial Estate, New Delhi, Delhi
110020

Page 6 of 12
PO No :PO2064551203-659

Name : Mr.R ARAVIND Client Name : TATA 1MG OKHLA

Age/Gender : 42/Male Registration Date : 07/Jul/2024 11:18AM
Patient ID : OKH1425357 Collection Date : 07/Jul/2024 09:11AM
Barcode ID/Order ID : D11724213 / 9998317 Sample Receive Date : 07/Jul/2024 01:21PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 07/Jul/2024 03:45PM

BIOCHEMISTRY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method
Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report.

Kidney Function Test.

Blood Urea Nitrogen 6 mg/dL 9-23 Urease with GLDH
Urea 13.10 mg/dl 19.26-49.22 Calculated
Creatinine 0.82 mg/dL 0.70-1.30 Alkaline picrate - kinetic
Uric Acid 6.9 mg/dL 3.5-7.2 Uricase/Peroxidase
Sodium 141 mmol/L 132-146 Indirect ISE
Potassium 4.00 mmol/L 3.5-5.5 Indirect ISE
Chloride 104.0 mmol/L 99-109 Indirect ISE
BUN/Creatinine Ratio 7.5 Ratio 12:1 - 20:1 Calculated

Comment:
BUN is directly related to protein intake and nitrogen metabolism and inversely related to the rate of excretion of urea.Blood
urea nitrogen (BUN) levels reflect the balance between the production and excretion of urea. Increased levels are seen in renal
failure (acute or chronic), urinary tract obstruction, dehydration, shock, burns, CHF, GI bleeding, nephrotoxic drugs. Decreased
levels are seen in hepatic failure, nephrotic syndrome, cachexia (low-protein and high-carbohydrate diets).
Urea is a non-proteinous nitrogen compound formed in the liver from ammonia as an end product of protein metabolism. Urea
diffuses freely into extracellular and intracellular fluid and is ultimately excreted by the kidneys. Increased levels are found in
acute renal failure, chronic glomerulonephritis, congestive heart failure, decreased renal perfusion, diabetes, excessive protein
ingestion, gastrointestinal (GI) bleeding, hyperalimentation, hypovolemia, ketoacidosis, muscle wasting from starvation,
neoplasms, pyelonephritis, shock, urinary tract obstruction, nephrotoxic drugs. Decreased levels are seen in inadequate dietary
protein, low-protein/high-carbohydrate diet, malabsorption syndromes, pregnancy, severe liver disease, certain drugs.
Creatinine is catabolic product of creatinine phosphate, which is excreted by filtration through the glomerulus and by tubular
secretion. Creatinine clearance is an acceptable clinical measure of glomerular filtration rate (GFR). Increased levels are seen in
acute/chronic renal failure, urinary tract obstruction, hypothyroidism, nephrotoxic drugs, shock, dehydration, congestive heart
failure, diabetes. Decreased levels are found in muscular dystrophy.
BUN/Creatinine ratio (normally 12:1–20:1) is decreased in acute tubular necrosis, advanced liver disease, low protein intake,
and following hemodialysis. BUN/Creatinine ratio is increased in dehydration, GI bleeding, and increased catabolism.
Uric acid levels show diurnal variation. The level is usually higher in the morning and lower in the evening. Increased levels are
seen in starvation, strenuous exercise, malnutrition, or lead poisoning, gout, renal disorders, increased breakdown of body cells
in some cancers (including leukemia, lymphoma, and multiple myeloma) or cancer treatments, hemolytic anemia, sickle cell
anemia, or heart failure, pre-eclampsia, liver disease (cirrhosis), obesity, psoriasis, hypothyroidism, low blood levels of
parathyroid hormone (PTH), certain drugs, foods that are very high in purines - such as organ meats, red meats, some seafood
and beer. Decreased levels are seen in liver disease, Wilson's disease, Syndrome of inappropriate antidiuretic hormone (SIADH),
certain drugs.

This test has been performed at

TATA 1MG OKHLA
Address: 2nd Floor, B-225, Okhla Phase I,
Okhla Industrial Estate, New Delhi, Delhi
110020

Page 7 of 12
PO No :PO2064551203-659

Name : Mr.R ARAVIND Client Name : TATA 1MG OKHLA

Age/Gender : 42/Male Registration Date : 07/Jul/2024 11:18AM
Patient ID : OKH1425357 Collection Date : 07/Jul/2024 09:11AM
Barcode ID/Order ID : D11724216 / 9998317 Sample Receive Date : 07/Jul/2024 01:43PM
Referred By : Dr. Report Status : Final Report
Sample Type : Urine Report Date : 08/Jul/2024 12:04AM

CLINICAL PATHOLOGY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method

Urine Routine & Microscopy

Colour Pale Yellow Pale Yellow
Appearance Clear Clear
Specific gravity 1.025 1.003 - 1.035 pKa change
pH 6.0 4.6 - 8.0 Double Indicator
Glucose Negative Negative GOD-POD
Protein Negative Negative Protein Error Principle
Ketones Negative Negative Nitroprusside
Blood Negative Negative Peroxidase
Bilirubin Negative Negative Diazonium
Urobilinogen Normal Normal Ehrlich
Leucocyte Esterase Negative Negative Pyrrole
Nitrite Negative Negative P-arsanilic acid
Pus cells 1-2 /hpf 0-5 Microscopy
Red Blood Cells Nil /hpf 0-2 Microscopy
Epithelial cells 1-2 /hpf Few Microscopy
Casts Nil /lpf Nil Microscopy
Crystals Nil Nil Microscopy
Yeast Nil Nil Microscopy
Bacteria Nil Nil Microscopy

Comment:
•Note: Pre-test condition to be observed while submitting the sample-first void, mid stream urine, collected in a clean, dry, sterile
container is recommended for routine urine analysis, avoid contamination with any discharge from vaginal, urethra, perineum,
Avoid prolonged transit time & undue exposure to sunlight.
•During interpretation, points to be considered are Negative nitrite test does not exclude the urinary tract infections. Trace
proteinuria can be seen with many physiological conditions like prolonged recumbency, exercise, high protein diet. False positive
reactions for bile pigments, proteins, glucose and nitrites can be caused by peroxidase like activity by disinfectants, therapeutic
dyes, ascorbic acid and certain drugs.• Urine microscopy is done in centrifuged urine specimens

This test has been performed at

TATA 1MG OKHLA
Address: 2nd Floor, B-225, Okhla Phase I,
Okhla Industrial Estate, New Delhi, Delhi
110020

Page 8 of 12
 PO No :PO2064551203-659

Name : Mr.R ARAVIND Client Name : TATA 1MG OKHLA

Age/Gender : 42/Male Registration Date : 07/Jul/2024 11:18AM
Patient ID : OKH1425357 Collection Date : 07/Jul/2024 09:11AM
Barcode ID/Order ID : D11724213 / 9998317 Sample Receive Date : 07/Jul/2024 01:21PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 07/Jul/2024 03:31PM

BIOCHEMISTRY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method

LIVER FUNCTION TEST

Liver Function Test
Bilirubin-Total 0.81 mg/dl 0.3 – 1.2 Vanadate oxidation
Bilirubin-Direct 0.27 mg/dl 0 - 0.3 Vanadate oxidation
Bilirubin-Indirect 0.54 mg/dL 0.2-0.8 Calculated
Protein, Total 7.87 g/dL 5.7-8.2 Biuret
Albumin 4.39 g/dL 3.4-4.8 BCG Dye Binding
Globulin 3.5 g/dl 2.1 - 3.9 Calculated
A/G Ratio 1.26 Ratio 0.8 - 2.1 Calculated
Aspartate Transaminase (SGOT) 25 U/L <34 Modified IFCC
Alanine Transaminase (SGPT) 37 U/L 10-49 Modified IFCC
SGOT/SGPT 0.68 Ratio <1 Calculated
Alkaline Phosphatase 67 U/L 46-116 IFCC Standardization
Gamma Glutamyltransferase (GGT) 24 U/L <73 Modified IFCC

Comment:
Useful for screening liver damage in suspected infections, digestive disorders, alcohol intake or certain drugs.

Raised ALT, AST indicate hepatocellular disease. ALT (more liver-specific) activity higher than AST in acute or chronic viral
hepatitis, autoimmune, hemochromatosis, medications/toxins etc, while higher AST activity in alcoholic hepatitis,
cirrhosis and non-hepatic causes like hemolysis, myopathy, thyroid disease, exercise etc. SGOT/SGPT ratio >1 seen in
alcoholic cirrhosis, metastasis; high ratio in cirrhosis correlates with the grade of fibrosis.
Mild isolated raised ALT, AST (<2 times normal) levels may require only repeat testing; usually resolve in 1/3rd cases. Most
common cause in asymptomatic cases is Fatty liver disease esp. in patients with metabolic syndrome (MASLD). Some
drugs (like paracetamol, statins), herbal supplements, energy drinks, and antibiotics may cause liver injury.
Elevated alkaline phosphatase and GGT indicate cholestatic disease like bile duct obstruction, primary biliary cirrhosis,
primary sclerosing cholangitis or infiltrating diseases of the liver. Also high in other causes like bone disease, pregnancy,
CRF, malignancies, congestive heart failure etc.
High bilirubin indicates jaundice either due to RBC breakdown, liver damage by infections, toxins; or cholestasis due to gall
stones, tumors etc.
High protein levels seen in dehydration (inadequate intake or excessive water loss) in severe vomiting, diarrhea, etc or
increased production seen in inflammation, some hematopoietic neoplasms. Low protein and albumin seen in impaired

This test has been performed at

TATA 1MG OKHLA
Address: 2nd Floor, B-225, Okhla Phase I,
Okhla Industrial Estate, New Delhi, Delhi
110020

Page 9 of 12
PO No :PO2064551203-659

Name : Mr.R ARAVIND Client Name : TATA 1MG OKHLA

Age/Gender : 42/Male Registration Date : 07/Jul/2024 11:18AM
Patient ID : OKH1425357 Collection Date : 07/Jul/2024 09:11AM
Barcode ID/Order ID : D11724213 / 9998317 Sample Receive Date : 07/Jul/2024 01:21PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 07/Jul/2024 03:31PM

BIOCHEMISTRY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method
synthesis (liver disease) or decreased intake, tissue damage, malabsorption and increased renal excretion.

This test has been performed at

TATA 1MG OKHLA
Address: 2nd Floor, B-225, Okhla Phase I,
Okhla Industrial Estate, New Delhi, Delhi
110020

Page 10 of 12
PO No :PO2064551203-659

Name : Mr.R ARAVIND Client Name : TATA 1MG OKHLA

Age/Gender : 42/Male Registration Date : 07/Jul/2024 11:18AM
Patient ID : OKH1425357 Collection Date : 07/Jul/2024 09:11AM
Barcode ID/Order ID : D11724213 / 9998317 Sample Receive Date : 07/Jul/2024 01:21PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 07/Jul/2024 03:31PM

Immunology
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method

Thyroid Profile
T3, Total 1.23 ng/mL 0.60-1.81 CLIA
T4, Total 9.5 µg/dl 4.5-12.6 CLIA
Thyroid Stimulating Hormone - Ultra 3.344 uIU/ml 0.55-4.78 CLIA
Sensitive

Comment:

Below mentioned are the guidelines for pregnancy related reference ranges for TSH, total T3 & Total T4.

Pregnancy
TSH (μIU/mL) (as per
American Thyroid Total T3 (ng/mL) Total T4(μg/dL)
Association )
1st trimester 0.1-2.5 0.81-1.90 7.33-14.8
2nd trimester 0.2-3.0 1.00-2.60 7.93-16.1
3rd trimester 0.3-3.0 1.00-2.60 6.95-15.7

TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a minimum between 6-10 pm
.
The variation is of the order of 50%, hence time of the day has influence on the measured serum TSH concentrations.
TSH is secreted in a dual fashion: Intermittent pulses constitute 60-70% of total amount, background continuous secretion
is 30-40%.These pulses occur regularly every 1-3 hrs.
Total T3 & T4 concentrations are altered by physiological or pathological changes in thyroxine binding globulin (TBG)
capacity .
The determination of free T3 & free T4 has the advantage of being independent of changes in the concentrations and
binding properties of the binding proteins.
Changes in thyroid status are typically associated with concordant changes in T3, T4 and TSH levels.
Unexpectedly abnormal or discordant thyroid test values may be seen with some rare, but clinically significant conditions
such as central hypothyroidism, TSH-secreting pituitary tumors, thyroid hormone resistance, or the presence of
heterophilic antibodies (HAMA) or thyroid hormone autoantibodies.
For diagnostic purposes, results should be used in conjunction with other data.

This test has been performed at

TATA 1MG OKHLA
Address: 2nd Floor, B-225, Okhla Phase I,
Okhla Industrial Estate, New Delhi, Delhi
110020

Page 11 of 12
 PO No :PO2064551203-659

Name : Mr.R ARAVIND Client Name : TATA 1MG OKHLA

Age/Gender : 42/Male Registration Date : 07/Jul/2024 11:18AM
Patient ID : OKH1425357 Collection Date : 07/Jul/2024 09:11AM
Barcode ID/Order ID : D11724213 / 9998317 Sample Receive Date : 07/Jul/2024 01:21PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 07/Jul/2024 03:31PM

Immunology
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method
TSH T3 T4 Interpretation
High Normal Normal Subclinical Hypothyroidism
Low Normal Normal Subclinical Hyperthyroidism
High High High Secondary Hyperthyroidism
Low High/Normal High/Normal Hyperthyroidism
Non thyroidal illness / Secondary
Low Low Low Hypothyroidism

*** End Of Report ***

Conditions of Laboratory Testing & Reporting:
Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should
be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report
may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal
purposes. Please mail your queries related to test results to Customer Care mall ID [email protected]

Disclaimer: Results relate only to the sample received. Test results marked "BOLD" indicate abnormal results i.e. higher or lower than normal. All
lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.
Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the
information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be
vetted by a qualified doctor only.

This test has been performed at

TATA 1MG OKHLA
Address: 2nd Floor, B-225, Okhla Phase I,
Okhla Industrial Estate, New Delhi, Delhi
110020

Page 12 of 12
 Ensuring accuracy IN every single report
Following a 3-step review process:

Advanced systems & Experienced lab experts Each report undergoes

cutting-edge technology analyze and technicians conduct rigorous medical scrutiny & is
results with precision comprehensive reviews signed off by a doctor

Have concerns regarding the report?

Reach out to our care team at [email protected]
or chat with us
CONNECT NOW >

Accurate Testing, Assured Quality: Diagnostics Precision

Stringent quality control Cutting-edge technology Experienced lab staff

Measures meeting Robust healthcare systems 30+ medical professionals
international norms of safety equipped with calibrated & with a collective
guidelines well-maintained machinery experience of 200+ years

Verified test procedures External assessments Trained phlebotomists

Highly standardized test Thorough third-party Ensuring smooth sample
procedures following CLSI* assessment by authorized collection experience &
guidelines experts pre-analytical precision

Claim FREE doctor consultation

Watch how
Consult top doctors from
the comfort of your home
we take care of
your sample
SCHEDULE NOW>

Get Second Opinion Order Medicines EXPLORE NOW >

Explore Financial Need Help?

Book Lab Tests
Support & more 1800-102-1618

*Clinical & Laboratory Standards Institute T&C Apply